Kader Turkekul

5PUBLICATIONS
4CO-AUTHORS
Predictive and prognostic markersMolecular medicineCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 14, 2024
Multifaceted impact of adipose conditioned media: Obesity-driven promotion of prostate cancer and cancer stem cell dynamics.

Suat Erdogan, Riza Serttas, Ilker Dibirdik

|Jan 11, 2024
Potent Suppression of Prostate Cancer Cell Growth and Eradication of Cancer Stem Cells by CD44-targeted Nanoliposome-quercetin Nanoparticles.

Kader Turkekul, Suat Erdogan

|Jun 15, 2022
The synergistic anticancer effect of salinomycin combined with cabazitaxel in CD44+ prostate cancer cells by downregulating wnt, NF-κB and AKT signaling.

Suat Erdogan, Riza Serttas, Kader Turkekul

|May 13, 2020
Neferine inhibits proliferation and migration of human prostate cancer stem cells through p38 MAPK/JNK activation.

Suat Erdogan, Kader Turkekul

|Feb 18, 2020
Neferine inhibits epidermal growth factor-induced proliferation and migration of retinal pigment epithelial cells through downregulating p38 MAPK and PI3K/AKT signalling.

Sadik Altan Ozal, Vuslat Gurlu, Kader Turkekul

Pageof 1

Frequent Collaborators

5 joint publications

Suat Erdogan

2 joint publications

Riza Serttas

2 joint publications

Ilker Dibirdik

1 joint publications

Sadik Altan Ozal